The Safety and Effectiveness of Droperidol for Sedation of Acute Behavioral Disturbance in the Emergency Department.

[1]  C. Adams,et al.  Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). , 2017, The Cochrane database of systematic reviews.

[2]  G. Isbister,et al.  Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram. , 2015, Annals of emergency medicine.

[3]  G. Isbister.  How do we assess whether the QT interval is abnormal: Myths, formulae and fixed opinion , 2015, Clinical toxicology.

[4]  G. Isbister,et al.  Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: Randomised controlled trial , 2015, British Journal of Psychiatry.

[5]  G. Isbister,et al.  A prospective study of high dose sedation for rapid tranquilisation of acute behavioural disturbance in an acute mental health unit , 2013, BMC Psychiatry.

[6]  G. Isbister,et al.  Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. , 2013, British journal of clinical pharmacology.

[7]  D. Taylor,et al.  Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial. , 2013, Annals of emergency medicine.

[8]  B. Stokes,et al.  Sedation assessment tool to score acute behavioural disturbance in the emergency department , 2011, Emergency medicine Australasia : EMA.

[9]  Michael A Downes,et al.  Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study. , 2010, Annals of emergency medicine.

[10]  B. Stokes,et al.  Inter-rater reliability of manual QT measurement and prediction of abnormal QT,HR pairs , 2009, Clinical toxicology.

[11]  Michael A Downes,et al.  Structured team approach to the agitated patient in the emergency department , 2009, Emergency medicine Australasia : EMA.

[12]  Ian Whyte,et al.  Safety and effectiveness of high‐dose midazolam for severe behavioural disturbance in an emergency department with suspected psychostimulant‐affected patients , 2008, Emergency medicine Australasia : EMA.

[13]  G K Isbister,et al.  Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. , 2007, QJM : monthly journal of the Association of Physicians.

[14]  D. Taylor,et al.  Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department. , 2006, Annals of emergency medicine.

[15]  James Miner,et al.  Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[16]  Kimberly Crimin,et al.  Dynamic Beat-to-Beat Modeling of the QT-RR Interval Relationship: Analysis of QT Prolongation during Alterations of Autonomic State versus Human Ether a-go-go-Related Gene Inhibition , 2005, Journal of Pharmacology and Experimental Therapeutics.

[17]  M. Kirk,et al.  Droperidol, QT prolongation, and sudden death: what is the evidence? , 2003, Annals of emergency medicine.

[18]  Peter B Chase,et al.  A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population. , 2002, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[19]  B. Horowitz,et al.  Droperidol--behind the black box warning. , 2002, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[20]  J. Richards,et al.  Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol. , 1998, The Journal of emergency medicine.